ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CSTL Castle Biosciences Inc

22,75
0,73 (3,32%)
Zuletzt aktualisiert: 19:12:53
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Castle Biosciences Inc CSTL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,73 3,32% 22,75 19:12:53
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
22,14 21,7379 22,755 22,02
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202422:30BWCastle Biosciences Kicks off Skin Cancer Awareness Month..
11.4.202413:00BWCastle Biosciences to Release First Quarter 2024 Financial..
10.4.202423:00BWCastle Biosciences Celebrates Esophageal Cancer Awareness..
10.4.202413:00BWCastle Biosciences’ Chief Financial Officer Frank Stokes..
04.4.202422:30BWPresentations at EADO Highlight Potential Impact of Castle..
02.4.202413:00BWCastle Biosciences to Present at the 23rd Annual Needham..
27.3.202422:00BWCastle Biosciences Announces Updates to its Board of..
25.3.202412:00BWCastle Biosciences Earns a Top Workplaces USA Award for the..
22.3.202421:30BWLong-term Outcomes Data Shared at SSO 2024 Show That..
19.3.202412:00BWLeading Squamous Cell Carcinoma Practitioners Publish..
15.3.202421:30BWNew Study Shows that the Drug-Drug Interactions and..
12.3.202412:00BWCastle Biosciences to Present at the KeyBanc Capital Markets..
08.3.202422:30BWCastle Biosciences to Present New Data Highlighting the..
07.3.202413:00BWIn Novel Cohort, New Data Confirms DecisionDx®-SCC Provides..
07.3.202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202423:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
28.2.202422:05BWCastle Biosciences Reports Fourth Quarter and Full-Year 2023..
26.2.202413:00BWStudy Finds DecisionDx®-Melanoma Significantly Improves the..
07.2.202413:00BWCastle Biosciences to Release Fourth Quarter and Full-Year..
18.1.202413:00BWNew Study Highlights Significant Potential Medicare Savings..
14.1.202410:30BWCastle Biosciences Presents Data Supporting the Utility of..
09.1.202413:00BWCastle Biosciences’ Chief Operating Officer Kristen..
08.1.202413:04EDGAR2Form 8-K - Current report
08.1.202402:00BWCastle Biosciences Announces Preliminary Fourth Quarter and..
04.1.202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202313:00BWCastle Biosciences Reports Inducement Grants Under Nasdaq..
13.12.202301:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202301:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202301:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202322:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
01.12.202313:00BWStudy Finds Nurse Practitioners and Physician Assistants..
14.11.202313:00BWCastle Biosciences Announces Multiple Data Presentations at..
13.11.202313:00BWCastle Biosciences Ranked Among the Top Workplaces in..
09.11.202323:25EDGAR2Form 8-K - Current report
08.11.202322:30BWReal-World Evidence Confirms IDgenetix®-Guided Medication..
08.11.202319:00BWCastle Biosciences to Present at Upcoming Investor..
03.11.202312:00BWCastle Announces Early Exploratory Study Data for Potential..
02.11.202321:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:06BWEarly Discovery Data Shows Ability of Castle Biosciences’..
02.11.202321:05BWCastle Biosciences Reports Third Quarter 2023 Results
24.10.202313:00BWCastle Biosciences to Present New Data on its TissueCypher®..
19.10.202313:00BWCastle Biosciences to Release Third Quarter 2023 Financial..
18.10.202322:30BWNew Data Highlights Clinical Utility and Performance of..
05.10.202313:00BWDecisionDx®-Melanoma Outperforms Memorial Sloan Kettering..
03.10.202313:00BWCastle Biosciences Presents New Data at ASTRO 2023..
02.10.202313:00BWCastle Biosciences Shares New Data Demonstrating Ability of..
25.9.202313:00BWCastle Biosciences, Leading Skin Cancer Expert, Darrell..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock